Engineered T cells beyond lymphoma and leukemia
Novel strategies for tumor targeting
Miltenyi's support to academic CGT development
Cell therapy development in academic settings
Enabling patient access to cell and gene therapies
Content
- Engineered T cells beyond lymphoma and leukemia
- Novel strategies for tumor targeting
- Miltenyi's support to academic CGT development
- Cell therapy development in academic settings
- Enabling patient access to cell and gene therapies